ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:07 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 326
Drug details and screening numbers
Drug Name: GSK690693
Drug ID: 326
Synonyms:
Brand name:
Target: AKT
Number of cell lines screened: 922
Screening concentration range(s): 0.04 to 10.24 uM
Statistically significant associations identified = 5
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a32 |
PTEN_mut |
326 |
1 |
1 |
GSK690693 |
AKT |
89 |
830 |
2.33 |
3.66 |
2.59 |
-1.08 |
0.62 . |
0.63 . |
0.53 . |
1.37e-08 |
7.63e-51 |
7.81e-02 |
0.0071 |
a101 |
CNOT1_mut |
326 |
1 |
1 |
GSK690693 |
AKT |
7 |
912 |
2.33 |
3.58 |
0.709 |
-2.87 |
1.6 * |
1.6 * |
1.4 * |
1.32e-05 |
4.66e-50 |
8.03e-02 |
2.1 |
a102 |
EWSR1-FLI1_mut |
326 |
1 |
1 |
GSK690693 |
AKT |
17 |
902 |
2.33 |
3.6 |
1.66 |
-1.94 |
1.1 * |
1.1 * |
0.95 . |
1.33e-05 |
4.67e-50 |
8.03e-02 |
2.1 |
a163 |
PIK3CA_mut |
326 |
1 |
1 |
GSK690693 |
AKT |
88 |
831 |
2.33 |
3.62 |
2.96 |
-0.664 |
0.38 |
0.38 |
0.38 |
5.13e-05 |
6.62e-50 |
8.08e-02 |
5.2 |
a418 |
TBX3_mut |
326 |
1 |
1 |
GSK690693 |
AKT |
4 |
915 |
2.33 |
3.57 |
1.35 |
-2.22 |
1.3 * |
1.3 * |
0.7 . |
5.13e-04 |
1.19e-49 |
8.15e-02 |
20 |
All-tests volcano plot